Literature DB >> 21052708

Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging.

Patricia H McNamara, Lisa Costelloe, Yvonne Langan, Janice Redmond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052708     DOI: 10.1007/s00415-010-5809-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Gluten sensitivity and neuromyelitis optica: two case reports.

Authors:  S Jacob; M Zarei; A Kenton; H Allroggen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 2.  Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.

Authors:  P Waters; Angela Vincent
Journal:  Int MS J       Date:  2008-09

3.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

4.  Two cases of benign neuromyelitis optica in patients with celiac disease.

Authors:  R Bergamaschi; S Jarius; M Robotti; A Pichiecchio; B Wildemann; G Meola
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

Review 5.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

6.  Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Authors:  Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Yusei Shiga; Chihiro Kanaoka; Juichi Fujimori; Shigeru Sato; Yasuto Itoyama
Journal:  Brain       Date:  2007-04-19       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.